Betydningen af mikroribonukleinsyre for sygdomsudvikling

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Betydningen af mikroribonukleinsyre for sygdomsudvikling. / Widjaya, Budiman; Seidelin, Jakob Benedict; Olsen, Jørgen; Nielsen, Ole Haagen.

In: Ugeskrift for Laeger, Vol. 171, No. 47, 16.11.2009, p. 3441-4.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Widjaya, B, Seidelin, JB, Olsen, J & Nielsen, OH 2009, 'Betydningen af mikroribonukleinsyre for sygdomsudvikling', Ugeskrift for Laeger, vol. 171, no. 47, pp. 3441-4.

APA

Widjaya, B., Seidelin, J. B., Olsen, J., & Nielsen, O. H. (2009). Betydningen af mikroribonukleinsyre for sygdomsudvikling. Ugeskrift for Laeger, 171(47), 3441-4.

Vancouver

Widjaya B, Seidelin JB, Olsen J, Nielsen OH. Betydningen af mikroribonukleinsyre for sygdomsudvikling. Ugeskrift for Laeger. 2009 Nov 16;171(47):3441-4.

Author

Widjaya, Budiman ; Seidelin, Jakob Benedict ; Olsen, Jørgen ; Nielsen, Ole Haagen. / Betydningen af mikroribonukleinsyre for sygdomsudvikling. In: Ugeskrift for Laeger. 2009 ; Vol. 171, No. 47. pp. 3441-4.

Bibtex

@article{1b691e0f962549c2aec72c7957bb592f,
title = "Betydningen af mikroribonukleinsyre for sygdomsudvikling",
abstract = "MicroRNAs (miRNAs) are small non-coding ribonucleic acids (RNAs) consisting of approximately 22 nucleotides which are believed to control posttranscriptional gene expression by targeting messenger RNA (mRNA) either by degradation or silencing. This article focuses on the importance of miRNAs in different diseases. There are observations or even evidence that miRNA is involved in the pathogenesis of diseases such as autoimmune, cancer, cardio-vascular, metabolic and infectious diseases. The manipulation of the expression of one or several specific miRNAs could prove to be a promising treatment option, and may improve diagnostics and therapeutics in future patient care.",
keywords = "Animals, Cardiovascular Diseases, Diabetes Mellitus, Gene Expression Regulation, Hepatitis C, Humans, Inflammatory Bowel Diseases, MicroRNAs, Neoplasms, English Abstract, Journal Article",
author = "Budiman Widjaya and Seidelin, {Jakob Benedict} and J{\o}rgen Olsen and Nielsen, {Ole Haagen}",
year = "2009",
month = nov,
day = "16",
language = "Dansk",
volume = "171",
pages = "3441--4",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "47",

}

RIS

TY - JOUR

T1 - Betydningen af mikroribonukleinsyre for sygdomsudvikling

AU - Widjaya, Budiman

AU - Seidelin, Jakob Benedict

AU - Olsen, Jørgen

AU - Nielsen, Ole Haagen

PY - 2009/11/16

Y1 - 2009/11/16

N2 - MicroRNAs (miRNAs) are small non-coding ribonucleic acids (RNAs) consisting of approximately 22 nucleotides which are believed to control posttranscriptional gene expression by targeting messenger RNA (mRNA) either by degradation or silencing. This article focuses on the importance of miRNAs in different diseases. There are observations or even evidence that miRNA is involved in the pathogenesis of diseases such as autoimmune, cancer, cardio-vascular, metabolic and infectious diseases. The manipulation of the expression of one or several specific miRNAs could prove to be a promising treatment option, and may improve diagnostics and therapeutics in future patient care.

AB - MicroRNAs (miRNAs) are small non-coding ribonucleic acids (RNAs) consisting of approximately 22 nucleotides which are believed to control posttranscriptional gene expression by targeting messenger RNA (mRNA) either by degradation or silencing. This article focuses on the importance of miRNAs in different diseases. There are observations or even evidence that miRNA is involved in the pathogenesis of diseases such as autoimmune, cancer, cardio-vascular, metabolic and infectious diseases. The manipulation of the expression of one or several specific miRNAs could prove to be a promising treatment option, and may improve diagnostics and therapeutics in future patient care.

KW - Animals

KW - Cardiovascular Diseases

KW - Diabetes Mellitus

KW - Gene Expression Regulation

KW - Hepatitis C

KW - Humans

KW - Inflammatory Bowel Diseases

KW - MicroRNAs

KW - Neoplasms

KW - English Abstract

KW - Journal Article

M3 - Tidsskriftartikel

C2 - 19925731

VL - 171

SP - 3441

EP - 3444

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 47

ER -

ID: 173051293